- Company Overview for ZYME DX LIMITED (14526873)
- Filing history for ZYME DX LIMITED (14526873)
- People for ZYME DX LIMITED (14526873)
- More for ZYME DX LIMITED (14526873)
Date (document was filed at Companies House) | Type | Description (of the document filed at Companies House) | View / Download (PDF file, link opens in new window) |
---|---|---|---|
10 Dec 2024 | CS01 | Confirmation statement made on 6 December 2024 with updates | |
03 Jul 2024 | AA | Micro company accounts made up to 31 December 2023 | |
14 Dec 2023 | CS01 | Confirmation statement made on 6 December 2023 with updates | |
08 Nov 2023 | PSC08 | Notification of a person with significant control statement | |
25 Oct 2023 | PSC07 | Cessation of Molly Morag Stevens as a person with significant control on 19 October 2023 | |
25 Oct 2023 | AP01 | Appointment of Doctor Leah Frenette as a director on 19 October 2023 | |
25 Oct 2023 | TM01 | Termination of appointment of Molly Morag Stevens as a director on 19 October 2023 | |
21 Aug 2023 | PSC01 | Notification of Molly Morag Stevens as a person with significant control on 31 July 2023 | |
21 Aug 2023 | PSC07 | Cessation of Rajesh Chaudhary as a person with significant control on 31 July 2023 | |
21 Aug 2023 | SH02 | Sub-division of shares on 31 July 2023 | |
21 Aug 2023 | SH01 |
Statement of capital following an allotment of shares on 31 July 2023
|
|
18 Aug 2023 | SH01 |
Statement of capital following an allotment of shares on 31 July 2023
|
|
17 Aug 2023 | MA | Memorandum and Articles of Association | |
17 Aug 2023 | RESOLUTIONS |
Resolutions
|
|
15 Aug 2023 | AP01 | Appointment of Prof Molly Morag Stevens as a director on 31 July 2023 | |
14 Aug 2023 | AP01 | Appointment of Dr Alexander Kurze as a director on 31 July 2023 | |
07 Dec 2022 | NEWINC |
Incorporation
Statement of capital on 2022-12-07
|